Consistently, prokineticin 2 (PK2), as a potential cytokine expressed in KCs, modulates the number of pro-inflammatory cells, thereby regulating their role in the progression of liver fibrosis after HBV infection (141). Here, TBCE is linked to Hepatic fibrosis.